Paper3918946
Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.
Schwartz R and 4 others. Int J Cancer, 1985. Cited by 86 papers, by iCite.
Cite this record
ConductScience Library. Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma. Papers, record 3918946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3918946
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Histocompatibility Antigens Class II | Major topic |
| Interferon-gamma | Major topic |
| Breast Neoplasms | |
| Cell Line | |
| Electrophoresis, Polyacrylamide Gel | |
| Female | |
| Fluorescent Antibody Technique | |
| HLA Antigens | |
| Humans | |
| Immunoenzyme Techniques | |
| Laryngeal Neoplasms | |
| Lung Neoplasms | |
| Uterine Cervical Neoplasms |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41227306 | Safety Assessment of Stem Cell-Based Therapies: Current Standards and Advancing Frameworks. | Cells | 2025 | https://conductscience.org/library/papers/41227306 | PubMed |
| 31564911 | Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31564911 | PubMed |
| 28315927 | HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients. | Cancer Immunol Immunother | 2017 | https://conductscience.org/library/papers/28315927 | PubMed |
| 24563618 | HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker. | Neoplasia | 2014 | https://conductscience.org/library/papers/24563618 | PubMed |
| 21572948 | Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma. | Transplant Proc | 1988 | https://conductscience.org/library/papers/21572948 | PubMed |
| 10849555 | Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity. | Gene Ther | 2000 | https://conductscience.org/library/papers/10849555 | PubMed |
| 8852397 | Autologous graft-versus-host disease. | Med Oncol | 1995 | https://conductscience.org/library/papers/8852397 | PubMed |
| 8400331 | Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8400331 | PubMed |
| 8124687 | MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8124687 | PubMed |
| 7737562 | Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells. | Gut | 1995 | https://conductscience.org/library/papers/7737562 | PubMed |
| 3722412 | Lymphocytic infiltration and survival in rectal cancer. | J Clin Pathol | 1986 | https://conductscience.org/library/papers/3722412 | PubMed |
| 3569495 | Interferon-beta can induce the production of plasminogen activator by cultured human cancer cells. | Experientia | 1987 | https://conductscience.org/library/papers/3569495 | PubMed |
| 3144087 | The relationship between epithelial Ia expression and the inflammatory cell infiltrate during experimental oral carcinogenesis. | Virchows Arch A Pathol Anat Histopathol | 1988 | https://conductscience.org/library/papers/3144087 | PubMed |
| 2227249 | Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine. | Gastroenterol Jpn | 1990 | https://conductscience.org/library/papers/2227249 | PubMed |
| 2108803 | Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines. | Cancer Immunol Immunother | 1990 | https://conductscience.org/library/papers/2108803 | PubMed |
| 2100410 | Rationale for immunotherapy of renal cell carcinoma. | Urol Res | 1990 | https://conductscience.org/library/papers/2100410 | PubMed |
| 1711927 | Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1711927 | PubMed |
| 1310252 | Three types of human lung tumour cell lines can be distinguished according to surface expression of endogenous urokinase and their capacity to bind exogenous urokinase. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1310252 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| MICA | 100507436 | PubTator's text mining | https://conductscience.org/library/genes/100507436 | NCBI Gene |
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3918946
GET https://conductscience.org/api/papers/v1/3918946/authors